Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Journal of human hypertension, Vol. 25, No. 11, 11.2011, p. 699-702.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis
AU - Sandoo, A
AU - Panoulas, V F
AU - Toms, T E
AU - Smith, J P
AU - Stavropoulos-Kalinoglou, A
AU - Metsios, G S
AU - Gasparyan, A Y
AU - Carroll, D
AU - Veldhuijzen van Zanten, J J C S
AU - Kitas, G D
PY - 2011/11
Y1 - 2011/11
KW - Adalimumab
KW - Antibodies, Monoclonal
KW - Antibodies, Monoclonal, Humanized
KW - Antirheumatic Agents
KW - Arthritis, Rheumatoid
KW - Blood Pressure
KW - Endothelium, Vascular
KW - England
KW - Etanercept
KW - Humans
KW - Immunoglobulin G
KW - Inflammation Mediators
KW - Infliximab
KW - Longitudinal Studies
KW - Microvessels
KW - Receptors, Tumor Necrosis Factor
KW - Time Factors
KW - Treatment Outcome
KW - Tumor Necrosis Factor-alpha
KW - Letter
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/jhh.2011.36
DO - 10.1038/jhh.2011.36
M3 - Article
C2 - 21525886
VL - 25
SP - 699
EP - 702
JO - Journal of human hypertension
JF - Journal of human hypertension
SN - 0950-9240
IS - 11
ER -